News for the Multiple Sclerosis Community

Biogen wants Fampridine

Biogen Idec Inc. is in talks to buy Acorda Therapeutics Inc. to gain an experimental pill (Fampridine) for patients with multiple sclerosis, people familiar with the discussions said.